Keywords: محلول HLA-G; HLA-G; human leukocyte antigen G; HLA-E; human leukocyte antigen E; PD-L1; programmed cell death 1 ligand 1; IL-10; interleukin-10; TGF-β; transforming growth factor beta; sHLA-G; soluble HLA-G; OL; oral leukoplakia; GB; granzyme B; OPL; oral precancerou
مقالات ISI محلول HLA-G (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Soluble HLA-G concentrations in obese women during pregnancy and in cord blood
Keywords: محلول HLA-G; Soluble HLA-G; Obesity; Pregnancy;
Allergen-driven HLA-G expression and secretion in peripheral blood mononuclear cells from allergic rhinitis patients
Keywords: محلول HLA-G; sHLA-G; soluble HLA-G; Th; T helper; PBMC; peripheral blood mononuclear cells; AR; allergic rhinitis; mAb; monoclonal antibody; MFI; mean fluorescence intensity; Tregs; regulatory T cells; HLA-G; Allergic rhinitis; CD4 T cells; Monocytes;
Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer
Keywords: محلول HLA-G; Gastric cancer; Soluble HLA-G; Tumor markers;
HLA-G profile of infertile couples who underwent assisted reproduction treatment
Keywords: محلول HLA-G; HLA-G regulatory region; HLA-G coding region; Human reproduction; Protective haplotype; Susceptibility haplotype; ART; assisted reproduction treatments; sHLA-G; soluble HLA-G; SNP; single nucleotide polymorphism;
Soluble HLA-G in pregnancies complicated by autoimmune rheumatic diseases
Keywords: محلول HLA-G; Soluble HLA-G; Rheumatic diseases; Pregnancy;
Human leukocyte antigen (HLA)-G and cervical cancer immunoediting: A candidate molecule for therapeutic intervention and prognostic biomarker?
Keywords: محلول HLA-G; 3â²UTR; untranslated region; 5â²URR; upstream regulatory region; ADC; cervical adenocarcinoma; AGUS; atypical glandular cells; APC; antigen presenting cells; ATG; start codon; Cd; cytoplasmatic domain; CD; cluster of differentiation; CIN; cervical intra
HLA-G5 in the blood of leukemia patients and healthy individuals
Keywords: محلول HLA-G; Soluble HLA-G; sHLA-G1; HLA-G5; B-CLL
Analysis of the plasma soluble human leukocyte antigen–G and interleukin-10 levels in childhood atopic asthma
Keywords: محلول HLA-G; HLA-G; Polymorphism; Soluble HLA-G; IL-10; Asthma
Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer
Keywords: محلول HLA-G; HLA-G; Soluble HLA-G; Breast cancer; Regulatory T cell;
Soluble total human leukocyte antigen class I and human leukocyte antigen–G molecules in kidney and kidney/pancreas transplantation
Keywords: محلول HLA-G; Soluble HLA-G; Total soluble HLA class I; Graft rejection; Kidney transplantation; Kidney/pancreas transplantation; Prognostic marker
How to predict implantation? No correlation between embryonic aneuploidy and soluble human leukocyte antigen G-concentrations
Keywords: محلول HLA-G; Soluble HLA-G; preimplantation genetic screening; PGD; implantation; embryo selection; aneuploidy
Graduated Embryo Score and soluble human leukocyte antigen-G expression improve assisted reproductive technology outcomes and suggest a basis for elective single-embryo transfer
Keywords: محلول HLA-G; Soluble HLA-G; sHLA-G; IVF; pregnancy; implantation; multiple gestation;
Soluble HLA-G in Rheumatoid Arthritis
Keywords: محلول HLA-G; Soluble HLA-G; soluble HLA class I; HLA-DRB1; HLA-DQB1; rheumatoid arthritis
Soluble human leukocyte antigen G expression in phase I culture media at 46 hours after fertilization predicts pregnancy and implantation from day 3 embryo transfer
Keywords: محلول HLA-G; Soluble HLA-G; sHLA-G; embryo marker; implantation; IVF;
Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma
Keywords: محلول HLA-G; Asthma; sHLA-G; IL-10; PBMC; MANOVA; Multiple ANOVA; PBS-Tween; PBS containing 0.05% Tween 20; rIL-10; Recombinant IL-10; sHLA-G; Soluble HLA-G;